Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, TX.
Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, DC.
Am J Obstet Gynecol. 2021 Nov;225(5):475.e1-475.e19. doi: 10.1016/j.ajog.2021.05.042. Epub 2021 Jun 2.
Women consider preservation of sexual activity and improvement of sexual function as important goals after pelvic organ prolapse surgery. This systematic review aimed to compare sexual activity and function before and after prolapse surgery among specific approaches to pelvic organ prolapse surgery including native tissue repairs, transvaginal synthetic mesh, biologic grafts, and sacrocolpopexy.
MEDLINE, Embase, and ClinicalTrials.gov databases were searched from inception to March 2021.
Prospective comparative cohort and randomized studies of pelvic organ prolapse surgeries were included that reported the following specific sexual function outcomes: baseline and postoperative sexual activity, dyspareunia, and validated sexual function questionnaire scores. Notably, the following 4 comparisons were made: transvaginal synthetic mesh vs native tissue repairs, sacrocolpopexy vs native tissue repairs, transvaginal synthetic mesh vs sacrocolpopexy, and biologic graft vs native tissue repairs.
Studies were double screened for inclusion and extracted for population characteristics, sexual function outcomes, and methodological quality. Evidence profiles were generated for each surgery comparison by grading quality of evidence for each outcome across studies using a modified Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.
Screening of 3651 abstracts was performed and identified 77 original studies. The overall quality of evidence was moderate to high. There were 26 studies comparing transvaginal synthetic mesh with native tissue repairs, 5 comparing sacrocolpopexy with native tissue repairs, 5 comparing transvaginal synthetic mesh with sacrocolpopexy, and 7 comparing biologic graft with native tissue repairs. For transvaginal synthetic mesh vs native tissue repairs, no statistical differences were found in baseline or postoperative sexual activity, baseline or postoperative total dyspareunia, persistent dyspareunia, and de novo dyspareunia. Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire short form change scores were not different between transvaginal synthetic mesh and native tissue repairs (net difference, -0.3; 95% confidence interval, -1.4 to 0.8). For sacrocolpopexy vs native tissue repairs, baseline or postoperative sexual activity, baseline or postoperative total dyspareunia, de novo dyspareunia, and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire short form score differences were not different. For biologic graft vs native tissue repairs, baseline or postoperative sexual activity, baseline or postoperative total dyspareunia, and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire short form changes were also not different. For transvaginal synthetic mesh vs sacrocolpopexy, there was no difference in sexual activity and sexual function score change. Based on 2 studies, postoperative total dyspareunia was more common in transvaginal synthetic mesh than sacrocolpopexy (27.5% vs 12.2%; odds ratio, 2.72; 95% confidence interval, 1.33-5.58). The prevalence of postoperative dyspareunia was lower than preoperative dyspareunia after all surgery types.
Sexual function comparisons are most robust between transvaginal synthetic mesh and native tissue repairs and show similar prevalence of sexual activity, de novo dyspareunia, and sexual function scores. Total dyspareunia is higher after transvaginal synthetic mesh than sacrocolpopexy. Although sexual function data are sparse in the other comparisons, no other differences in sexual activity, dyspareunia, and sexual function score change were found.
女性将保留性行为和改善性功能视为盆腔器官脱垂手术后的重要目标。本系统评价旨在比较特定盆腔器官脱垂手术方法(包括天然组织修复、经阴道合成网片、生物移植物和骶骨阴道固定术)前后的性行为和功能。
从建库到 2021 年 3 月,检索了 MEDLINE、Embase 和 ClinicalTrials.gov 数据库。
包括盆腔器官脱垂手术的前瞻性比较队列和随机研究,报告了以下特定性功能结果:基线和术后性行为、性交痛和经过验证的性功能问卷评分。值得注意的是,进行了以下 4 种比较:经阴道合成网片与天然组织修复、骶骨阴道固定术与天然组织修复、经阴道合成网片与骶骨阴道固定术以及生物移植物与天然组织修复。
对纳入的研究进行了双次筛选并提取了人群特征、性功能结果和方法学质量。使用改良的推荐评估、制定与评估(GRADE)系统对每个手术比较生成证据概况,通过对研究中每个结果的证据质量进行分级来评估每个结果的质量。
对 3651 篇摘要进行了筛选,确定了 77 项原始研究。总体证据质量为中等到高度。有 26 项研究比较了经阴道合成网片与天然组织修复,5 项研究比较了骶骨阴道固定术与天然组织修复,5 项研究比较了经阴道合成网片与骶骨阴道固定术,7 项研究比较了生物移植物与天然组织修复。经阴道合成网片与天然组织修复相比,基线或术后性行为、基线或术后总性交痛、持续性性交痛和新发性交痛无统计学差异。经阴道合成网片与天然组织修复相比,盆腔器官脱垂/尿失禁性功能问卷短表评分变化无差异(差值,-0.3;95%置信区间,-1.4 至 0.8)。骶骨阴道固定术与天然组织修复相比,基线或术后性行为、基线或术后总性交痛、新发性交痛和盆腔器官脱垂/尿失禁性功能问卷短表评分差异无统计学意义。生物移植物与天然组织修复相比,基线或术后性行为、基线或术后总性交痛和盆腔器官脱垂/尿失禁性功能问卷短表评分变化也无差异。经阴道合成网片与骶骨阴道固定术相比,性行为和性功能评分变化无差异。基于 2 项研究,经阴道合成网片术后总性交痛发生率高于骶骨阴道固定术(27.5%比 12.2%;比值比,2.72;95%置信区间,1.33-5.58)。所有手术类型术后性交痛的发生率均低于术前。
经阴道合成网片与天然组织修复之间的性功能比较最可靠,显示出相似的性行为、新发性交痛和性功能评分发生率。经阴道合成网片术后总性交痛发生率高于骶骨阴道固定术。尽管其他比较中性功能数据较少,但未发现性行为、性交痛和性功能评分变化的其他差异。